Sport Integrity Australia acknowledges the decision of the QRL Anti-Doping Tribunal to sanction athlete Heath Wilson for the presence of a metabolite of a prohibited substance, the use of a prohibited substance, and tampering or attempted tampering with any part of Doping Control.
Mr Wilson returned an Adverse Analytical Finding (AAF) from an out-of-competition doping control test on 3 March 2020.
His sample detected the presence of Di-Hydroxy LGD-4033 (a metabolite of LGD-4033).
It was determined that on and/or before 3 March 2020 Mr Wilson used LGD-4033, which is prohibited in and out-of-competition under the S1 Class of Anabolic Agents.
It was also determined that on and/or between 18 May 2020 and 19 May 2020, Mr Wilson tampered or attempted to tamper with a part of Doping Control.
The QRL Anti-Doping Tribunal imposed a four-year ban on Mr Wilson commencing on 19 May 2020.
Mr Wilson is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 19 May 2024.
ADDITIONAL INFORMATION ON THE PROHIBITED SUBSTANCE
LGD-4033, originally developed for the treatment of muscle wasting conditions such as aging, osteoporosis, muscular dystrophy and cancer, is promoted as a selective non-steroidal anabolic agent.
It is claimed to be a substance that induces muscle (and bone) growth without the side effects associated with steroid use. However, information on the safety of LGD-4033 is scarce due to a lack of medium and long-term clinical trials – hence the medium and long-term health impacts are unknown.
It should be noted that a number of Selective Androgen Receptor Modulators (SARMs) have associated health-risks, particularly for the heart and liver.
Sport Integrity Australia is committed to protecting the right of clean athletes to fair competition. If you are aware of any suspicious doping activity, you can report it anonymously via the Sport Integrity Australia website